Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Testing effectiveness (Phase 2)WithdrawnNCT03862079
What this trial is testing

Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics

Who this might be right for
Graft-versus-host Disease Prevention
M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05256537
What this trial is testing

Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

Who this might be right for
Hematologic Neoplasms
Ronald Paquette 60
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Not applicableStudy completedNCT07335471
What this trial is testing

Prevention and Management of Cardiovascular and Cerebrovascular Complications in Maintenance Hemodialysis (MHD) Patients

Who this might be right for
Uremia; ChronicCardiovascular Diseases (CVD)Cerebrovascular Disorders+3 more
Suzhou Municipal Hospital of Anhui Province 100
Testing effectiveness (Phase 2)Study completedNCT04686929
What this trial is testing

Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Who this might be right for
AbataceptAcute-graft-versus-host DiseaseHaplo-identical HCT+1 more
The First Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)UnknownNCT02659657
What this trial is testing

Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation

Who this might be right for
Acute Graft-versus-host Disease
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)Study completedNCT02891603
What this trial is testing

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

Who this might be right for
Graft Vs Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 40
Large-scale testing (Phase 3)Study completedNCT03959241
What this trial is testing

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Who this might be right for
Acute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more
Medical College of Wisconsin 431
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01607580
What this trial is testing

Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)

Who this might be right for
Leukemia
Peking University People's Hospital 145
Testing effectiveness (Phase 2)Study completedNCT02248597
What this trial is testing

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Looking for participantsNCT06880419
What this trial is testing

Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model

Who this might be right for
Acute Graft-versus-Host Disease
Institute of Hematology & Blood Diseases Hospital, China 174
Early research (Phase 1)WithdrawnNCT00524953
What this trial is testing

Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT

Who this might be right for
Allogeneic Transplantation (Non T-cell Depleted)
Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT00391170
What this trial is testing

Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease

Who this might be right for
Graft vs Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 62
Not applicableStudy completedNCT04869254
What this trial is testing

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantation
IRCCS Burlo Garofolo 102
Post-approval studies (Phase 4)Study completedNCT01856803
What this trial is testing

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Who this might be right for
Leukemia, GVHD, ATG, Transplantation
Peking University People's Hospital 300
Post-approval studies (Phase 4)Ended earlyNCT01282879
What this trial is testing

Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients

Who this might be right for
Graft vs Host Disease
Samsung Medical Center 36
Next Page